UPDATED Mar 04, 2024
Defensive mid-caps and large-caps in descending order of expected ROE in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
1099Sinopharm Group | HK$21.60 | -2.7% | -4.0% | HK$67.4b | HK$27.70 | PE7.1x | E6.6% | 4.1% | ||
1066Shandong Weigao Group Medical Polymer | HK$4.88 | -6.5% | -60.9% | HK$22.3b | HK$11.45 | PE8.6x | E10.9% | 3.4% | ||
874Guangzhou Baiyunshan Pharmaceutical Holdings | HK$20.70 | 0.5% | -14.5% | HK$50.5b | HK$25.33 | PE7.2x | E1.5% | 3.9% |